New Delhi: The Department of Pharmaceuticals has invited comments from stakeholders on the proposals received for amendments to the Global Tender Enquiry (GTE) Exemption List of Medical Devices. Following a Public Notice issued on 11 February 2026 seeking feedback on the existing GTE Exemption List, the Department received representations from various stakeholders requesting addition, deletion and/or modification of entries under the list.
All concerned stakeholders, including domestic manufacturers, importers, industry associations, procurement agencies and healthcare institutions, have been requested to submit their comments along with supporting information on or before 15 July 2026 through email at [email protected] with a copy to [email protected].